Carrington to sell products in Italy through Recordati:
This article was originally published in Clinica
Executive Summary
Carrington Laboratories, a woundcare company, has signed a 10- year distribution and marketing agreement with the Italian company Recordati Chemical and Pharmaceutical. Recordati, which is to sell Carrington's woundcare and oral products in Italy, will register Carrington's products for sale and reimbursement in Italy. The company is to pay a six-figure amount for the rights within 30 days, with two further, similar payments due when milestones are reached. Carrington is to pursue CE-marking for its products.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.